98 related articles for article (PubMed ID: 24706695)
21. Maternal and fetal serum transformed alpha-fetoprotein levels in normal pregnancy.
González-Bugatto F; Foncubierta E; Bailén Mde L; Illanes S; Hervías-Vivancos B; Bartha JL
J Obstet Gynaecol Res; 2009 Apr; 35(2):271-6. PubMed ID: 19453690
[TBL] [Abstract][Full Text] [Related]
22. The use of α-fetoprotein for the delivery of cytotoxic payloads to cancer cells.
Pak V
Ther Deliv; 2014 Aug; 5(8):885-92. PubMed ID: 25337646
[TBL] [Abstract][Full Text] [Related]
23. AFP peptide (AFPep) as a potential growth factor for prostate cancer.
Zhu Z; West GR; Wang DC; Collins AB; Xiao H; Bai Q; Mesfin FB; Wakefield MR; Fang Y
Med Oncol; 2021 Nov; 39(1):2. PubMed ID: 34739644
[TBL] [Abstract][Full Text] [Related]
24. [Significant effects on alpha-fetoprotein (AFP) concentration in maternal serum in pregnancy].
Greiff R; Schlosser H; Amse T
Zentralbl Gynakol; 1991; 113(5):253-7. PubMed ID: 1711749
[TBL] [Abstract][Full Text] [Related]
25. Deletion of serum lectin-reactive alpha-fetoprotein by acyclic retinoid: a potent biomarker in the chemoprevention of second primary hepatoma.
Moriwaki H; Yasuda I; Shiratori Y; Uematsu T; Okuno M; Muto Y
Clin Cancer Res; 1997 May; 3(5):727-31. PubMed ID: 9815742
[TBL] [Abstract][Full Text] [Related]
26. Hypertension, pregnancy, and risk of breast cancer.
Thompson WD; Jacobson HI; Negrini B; Janerich DT
J Natl Cancer Inst; 1989 Oct; 81(20):1571-4. PubMed ID: 2477555
[TBL] [Abstract][Full Text] [Related]
27. Reproductive factors and extreme levels of maternal serum alpha-fetoprotein: a population-based study.
Lei U; Wohlfahrt J; Christens P; Westergaard T; Lambe M; Nørgaard-Pedersen B; Melbye M
Acta Obstet Gynecol Scand; 2004 Dec; 83(12):1147-51. PubMed ID: 15548147
[TBL] [Abstract][Full Text] [Related]
28. [Research advances on alpha-fetoprotein physiological function and clinical potential].
Yin ZF; Wang CH
Ai Zheng; 2003 Jan; 22(1):108-11. PubMed ID: 12561448
[TBL] [Abstract][Full Text] [Related]
29. The recombinant third domain of human alpha-fetoprotein retains the antiestrotrophic activity found in the full-length molecule.
Festin SM; Bennett JA; Fletcher PW; Jacobson HI; Shaye DD; Andersen TT
Biochim Biophys Acta; 1999 Apr; 1427(2):307-14. PubMed ID: 10216247
[TBL] [Abstract][Full Text] [Related]
30. Effects of parity on pregnancy hormonal profiles across ethnic groups with a diverse incidence of breast cancer.
Arslan AA; Zeleniuch-Jacquotte A; Lukanova A; Afanasyeva Y; Katz J; Levitz M; Del Priore G; Toniolo P
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2123-30. PubMed ID: 17119037
[TBL] [Abstract][Full Text] [Related]
31. Update of alpha fetoprotein growth-inhibitory peptides as biotherapeutic agents for tumor growth and metastasis.
Mizejewski GJ; Muehlemann M; Dauphinee M
Chemotherapy; 2006; 52(2):83-90. PubMed ID: 16498241
[TBL] [Abstract][Full Text] [Related]
32. Elevated maternal serum alpha-fetoprotein levels and maternal risk factors. Their association with pregnancy complications.
Capeless EL; Kelleher PC; Walters CP
J Reprod Med; 1992 Mar; 37(3):257-60. PubMed ID: 1373447
[TBL] [Abstract][Full Text] [Related]
33. Detection and measurement of alpha-fetoprotein in human breast cancer cytosol after treatment with 0.4 M potassium chloride.
Sarcione EJ; Zloty M; Delluomo DS; Mizejewski G; Jacobson H
Cancer Res; 1983 Aug; 43(8):3739-41. PubMed ID: 6190555
[TBL] [Abstract][Full Text] [Related]
34. A peptide derived from alpha-fetoprotein inhibits the proliferation induced by estradiol in mammary tumor cells in culture.
Sierralta WD; Epuñan MJ; Reyes JM; Valladares LE; Andersen TT; Bennett JA; Jacobson HI; Pino AM
Oncol Rep; 2008 Jan; 19(1):229-35. PubMed ID: 18097600
[TBL] [Abstract][Full Text] [Related]
35. A cyclic peptide derived from alpha-fetoprotein inhibits the proliferative effects of the epidermal growth factor and estradiol in MCF7 cells.
Torres C; Antileo E; Epuñán MJ; Pino AM; Valladares LE; Sierralta WD
Oncol Rep; 2008 Jun; 19(6):1597-603. PubMed ID: 18497971
[TBL] [Abstract][Full Text] [Related]
36. Estrogen and alpha-fetoprotein levels in maternal and umbilical cord blood samples in relation to birth weight.
Nagata C; Iwasa S; Shiraki M; Shimizu H
Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1469-72. PubMed ID: 16896034
[TBL] [Abstract][Full Text] [Related]
37. [High-efficient renaturation of immobilized recombinant C-terminal fragment of human alpha-fetoprotein].
Sharapova OA; Iurkova MS; Andronova SM; Fedorov AN; Severin SE; Severin ES
Prikl Biokhim Mikrobiol; 2011; 47(5):523-9. PubMed ID: 22232892
[TBL] [Abstract][Full Text] [Related]
38. Antitumor activity of alpha-fetoprotein conjugate with doxorubicin in vitro and in vivo.
Feldman NB; Kiselev SM; Gukasova NV; Posypanova GA; Lutsenko SV; Severin SE
Biochemistry (Mosc); 2000 Aug; 65(8):967-71. PubMed ID: 11002192
[TBL] [Abstract][Full Text] [Related]
39. Maternal serum alpha-fetoprotein level during pregnancy and isolated cryptorchidism in male offspring.
Boyd HA; Myrup C; Wohlfahrt J; Westergaard T; Nørgaard-Pedersen B; Melbye M
Am J Epidemiol; 2006 Sep; 164(5):478-86. PubMed ID: 16790515
[TBL] [Abstract][Full Text] [Related]
40. Alpha-fetoprotein growth inhibitory peptides: potential leads for cancer therapeutics.
Mizejewski GJ; MacColl R
Mol Cancer Ther; 2003 Nov; 2(11):1243-55. PubMed ID: 14617798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
